Memo Therapeutics in a €26 million Series C led by Pureos Bioventures, with Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders

Biotech Health services Manufacturing

Investments

30 October 2023

Memo Therapeutics (company)

Biotech Health services Manufacturing

Total investments received (USD): 112.24m

Round value (USD): 27.56m

Round investors: Adjuvant Capital Verve Ventures Pureos Bioventures Redalpine Schroders Swisscanto Invest Vesalius Biocapital Partners Fresenius Medical Care Ventures GF Group

Company: Memo Therapeutics

Industry: Biotech Health services Manufacturing

Related deals

LEM Surgical raised €23.6 million series B

Health services Manufacturing Robotics

Investments 24 December 2023

Granite Bio raised a $30m Series A round co-led by Versant Ventures and Novartis Venture Fund

Biotech Health services Manufacturing

Investments 24 December 2023

Vandria in a CHF18 million series A round led by ND Capital together with a small syndicate of HNW private investors.

Biotech Health services Manufacturing Pharma

Investments 15 December 2023

Mootral raised $20 million led by King Philanthropies, joined by Lowercarbon Capital, Kindred Ventures, Third Derivative, and Climate Capital.

Agriculture Biotech Energy Manufacturing Social Responsibility

Investments 06 December 2023

4D Lifetec raised CHF 23.3 million with Xlife Sciences AG

Biotech Health services

Investments 13 October 2023

Menu

Memo Therapeutics in a €26 million Series C led by Pureos Bioventures, with Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders

Share:

Memo Therapeutics (company)

Related deals

LEM Surgical raised €23.6 million series B

Granite Bio raised a $30m Series A round co-led by Versant Ventures and Novartis Venture Fund

Vandria in a CHF18 million series A round led by ND Capital together with a small syndicate of HNW private investors.

Mootral raised $20 million led by King Philanthropies, joined by Lowercarbon Capital, Kindred Ventures, Third Derivative, and Climate Capital.

4D Lifetec raised CHF 23.3 million with Xlife Sciences AG

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe